DaVita Inc. (NYSE:DVA) Position Reduced by 8 Knots Management LLC

8 Knots Management LLC trimmed its holdings in shares of DaVita Inc. (NYSE:DVA) by 1.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 680,882 shares of the company’s stock after selling 9,840 shares during the period. DaVita comprises 10.2% of 8 Knots Management LLC’s investment portfolio, making the stock its 4th largest position. 8 Knots Management LLC’s holdings in DaVita were worth $101,826,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Lido Advisors LLC lifted its holdings in shares of DaVita by 46.4% during the 4th quarter. Lido Advisors LLC now owns 2,718 shares of the company’s stock valued at $406,000 after acquiring an additional 862 shares in the last quarter. Northern Trust Corp raised its position in DaVita by 12.5% in the fourth quarter. Northern Trust Corp now owns 740,774 shares of the company’s stock valued at $110,783,000 after purchasing an additional 82,326 shares during the period. Beacon Pointe Advisors LLC purchased a new position in DaVita in the fourth quarter valued at about $224,000. Nebula Research & Development LLC purchased a new stake in shares of DaVita in the fourth quarter worth about $432,000. Finally, Kovitz Investment Group Partners LLC acquired a new stake in shares of DaVita in the fourth quarter valued at about $322,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on DVA shares. Cowen reissued a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Barclays lifted their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st. Finally, StockNews.com upgraded DaVita from a “hold” rating to a “buy” rating in a research note on Friday. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $166.33.

DaVita Trading Up 0.8 %

NYSE DVA opened at $140.64 on Tuesday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The company has a 50-day simple moving average of $146.22 and a 200-day simple moving average of $155.10. DaVita Inc. has a one year low of $131.27 and a one year high of $179.60. The firm has a market capitalization of $11.25 billion, a PE ratio of 13.09, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.